Physician profile
Dennis Padla
NPI 1295728921
$3,622.79
in general payments reported to CMS, 2019-2025
17 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $358 · 2021: $129 · 2022: $600 · 2023: $544 · 2024: $506 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,019.69 | 2019-2025 | Lybalvi, Aristada |
| Janssen Pharmaceuticals, INC | $566.72 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $541.38 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $248.64 | 2020-2025 | Austedo Xr |
| Axsome Therapeutics, INC. | $243.68 | 2024-2025 | Auvelity |
| Abbvie INC. | $190.21 | 2023-2024 | |
| Novo Nordisk INC | $144.37 | 2023 | Wegovy, Saxenda |
| Neurocrine Biosciences, INC. | $143.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2024 | Cobenfy |
| Acadia Pharmaceuticals INC | $112.01 | 2020 | |
| Janssen Scientific Affairs, LLC | $97.96 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.02 | 2024 | Caplyta |
| Almatica Pharma LLC | $31.20 | 2022 | |
| Sage Therapeutics, LLC | $26.78 | 2025 | Zurzuvae |
| Lilly USA, LLC | $22.52 | 2024 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.79 | 2019 | |
| Hologic Sales and Service, LLC | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Padla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.